A new series of triazolothiadiazines as potential anticancer agents for targeted therapy of non-small cell lung and colorectal cancers: design, synthesis, in silico and in …

B Sever, MD Altıntop, GA Çiftçi… - Medicinal …, 2021 - ingentaconnect.com
Background: Targeted therapies acting on specific molecular targets in cancer cells with
better curative efficacy and lower toxicity have come into prominence for the management of …

The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches

EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara… - Processes, 2022 - mdpi.com
Corresponding to the reported features of anti-VEGFR-2-approved compounds, a new 1 H-
indole derivative (compound 7) was designed. The inhibitory potential of the designed …

Synthesis of [1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine-1, 2, 3-triazoles as potent EGFR targeting anti-breast cancer agents

S Chirra, R Gondru, M Manne, M Azam… - Journal of Molecular …, 2024 - Elsevier
Synthetic chemists have organized easy and effective ways for perfect synthesis in response
to the requirement for scaffolds that are crucial for medical applications. A general strategy …

In-silico identification of small molecule benzofuran-1, 2, 3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore …

S Kumar, I Ali, F Abbas, N Khan, MK Gupta… - In Silico …, 2023 - Springer
Lung cancer is one of the most common and deadly types of cancer worldwide, and the
epidermal growth factor receptor (EGFR) has emerged as a promising therapeutic target for …

Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis

AS El-Azab, AM Alaa, NA AlSaif, HM Alkahtani… - Bioorganic …, 2020 - Elsevier
The in vitro cytotoxicity of some substituted quinazolinones, 1–15, was evaluated using NCI
(10 µM) in a full NCI 59–cell line panel assay. Relative to the reference drug, imatinib (PCE …

New thiazolidine-2, 4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies

H Elkady, HA Mahdy, MS Taghour, MA Dahab… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Background VEGFR-2 has emerged as a prominent positive regulator of cancer
progression. Aim Discovery of new anticancer agents and apoptotic inducers targeting …

Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by …

AKB Aljohani, WAZ El Zaloa, M Alswah… - International journal of …, 2023 - mdpi.com
Phenylpyrazolo [3, 4-d] pyrimidine is considered a milestone scaffold known to possess
various biological activities such as antiparasitic, antifungal, antimicrobial, and …

Targeting EGFR tyrosine kinase: Synthesis, in vitro antitumor evaluation, and molecular modeling studies of benzothiazole-based derivatives

AM Mokhtar, SM El-Messery, MA Ghaly, GS Hassan - Bioorganic chemistry, 2020 - Elsevier
New benzothiazole-based derivatives were synthesized in the present work with the aim of
evaluating their antitumor activity. They were in vitro tested against hepatocellular carcinoma …

Novel series of benzo [d] thiazolyl substituted-2-quinolone hybrids: Design, synthesis, biological evaluation and in-silico insights

G Bolakatti, M Palkar, M Katagi, G Hampannavar… - Journal of Molecular …, 2021 - Elsevier
Abstract A novel series of 3-(2-(4-(substituted-benzo [d] thiazol-2-yl) phenylamino) acetyl)-4‑
hydroxy-1-methyl/phenyl quinolin-2 (1H)-one (7a-f and 8a-f) were synthesized. Reaction of …

Design, synthesis, molecular docking, and anticancer evaluation of pyrazole linked pyrazoline derivatives with carbothioamide tail as EGFR kinase inhibitors

F Nawaz, O Alam, A Perwez, MA Rizvi… - Anti-Cancer Agents …, 2021 - ingentaconnect.com
Background: The Epidermal Growth Factor Receptor (known as EGFR) induces cell
differentiation and proliferation upon activation through the binding of its ligands. Since …